Farhad Hafezi

SmILE more solid than flap-based refractive laser surgery: this recently published research, spearheaded by Walter Sekundo from Germany, shows for the first time that SmILE indeed is biomechanically more solid than flap-based refractive laser surgery approaches
After 4 years of preparation, the new Research Laboratory for Ocular Cell Biology and Biomechanics opens at the USC Roski Eye Institute.
Algorithm predicts CXL effect: in this scientific article, we published a new algorithm that combines the knowledge we accumulated over the past 12 years
The ELZA founder Farhad Hafezi gives an invited lecture on “Past, Present and Future of Cross-Linking”
We are currently developing the technique of slit lamp cross-linking, one crucial step will be to determine whether riboflavin, once applied onto the cornea, remains at saturation levels during a CXL procedure
“Sitting down with” is an interview series of the journal The Ophthalmologist covering selected personalities in ophthalmology.
ELZA founder Prof. Farhad Hafezi speaks about treating therapy-resistant corneal infections with cross-linking (PACK-CXL).
ELZA speaks at the Praxisseminar of Schwind eye-tech solutions about “Postoperative management after trans-PRK”.
The ELZA Institute, represented by Dr. Emilio Torres and Prof. Farhad Hafezi, gave 4 presentations and a course on Corneal Cross-Linking.
In this scientific article, we supported the research of our partner group around Prof. Simon Pot, a renowned veterinary ophthalmologist.
.
.